Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Despite some individual studies reporting small benefits, more methodologically rigorous trials failed to show meaningful effects
Dapagliflozin in patients with chronic kidney Disease
A control group of about 300 patients took SGLT-2 inhibitors (e.g., canagliflozin, dapagliflozin, empagliflozin), drugs that are comparable to GLP-1 receptor agonists at lowering blood glucose levels
H., Sherpa, M
US$ 22.59
US$ 25.60
US$ 26.21
US$ 26.89
US$ 23.47
US$ 25.02
